{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:26:38Z","timestamp":1762100798287},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hepatobiliary Pancreat Surg"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00534-007-1298-2","type":"journal-article","created":{"date-parts":[[2008,4,5]],"date-time":"2008-04-05T08:49:50Z","timestamp":1207385390000},"page":"131-138","source":"Crossref","is-referenced-by-count":55,"title":["Current status of liver transplantation across ABO blood-type barrier"],"prefix":"10.1007","volume":"15","author":[{"given":"Hiroto","family":"Egawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ohdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuaki","family":"Tsuruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Oike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,6]]},"reference":[{"key":"1298_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jlts.2003.50011","volume":"9","author":"D.W. Hanto","year":"2003","unstructured":"Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003;9:22\u201330.","journal-title":"Liver Transpl"},{"issue":"12","key":"1298_CR2","first-page":"1324","volume":"9","author":"R. Troisi","year":"2006","unstructured":"Troisi R, Noens L, Montalti R, Ricciardi S, Philippe J, Praet M, et al. ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl 2006;9:12:1324\u20131325.","journal-title":"Liver Transpl"},{"key":"1298_CR3","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/lt.20760","volume":"12","author":"T. Heffron","year":"2006","unstructured":"Heffron T, Welch D, Pillen T, Asolati M, Smallwood G, Hagedorn P, et al. Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis. Liver Transpl 2006;12:972\u2013978.","journal-title":"Liver Transpl"},{"key":"1298_CR4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/lt.21092","volume":"13","author":"H. Egawa","year":"2007","unstructured":"Egawa H, Ohmori K, Haga H, Tsuji H, Yurugi K, Miyagawa-Hayashino A, et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl 2007;13:579\u2013588.","journal-title":"Liver Transpl"},{"key":"1298_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.TP.0000110295.88926.5C","volume":"77","author":"H. Egawa","year":"2004","unstructured":"Egawa H, Oike F, Buhler L, Shapiro AMJ, Minamiguchi S, Haga H, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004;77:403\u2013411.","journal-title":"Transplantation"},{"key":"1298_CR6","doi-asserted-by":"crossref","unstructured":"Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2007 Oct 10 [Epub ahead of print]","DOI":"10.1002\/hep.21928"},{"key":"1298_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/lt.20002","volume":"10","author":"H. Haga","year":"2004","unstructured":"Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 2004;10:16\u201327.","journal-title":"Liver Transpl"},{"key":"1298_CR8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/01.TP.0000137264.99113.2B","volume":"78","author":"D. Morioka","year":"2004","unstructured":"Morioka D, Sekido H, Kubota K, Sugita M, Tanaka K, Togo S, et al. Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis. Transplantation 2004;78:1225\u20131228.","journal-title":"Transplantation"},{"key":"1298_CR9","first-page":"489","volume":"132","author":"A.J. Demetris","year":"1988","unstructured":"Demetris AJ, Jaffe R, Tzakis A, Ramsey G, Todo S, Belle S, et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988;132:489\u2013502.","journal-title":"Am J Pathol"},{"key":"1298_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.20652","volume":"12","author":"H. Haga","year":"2006","unstructured":"Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, et al.. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006;12:457\u2013464.","journal-title":"Liver Transpl"},{"key":"1298_CR11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/modpathol.3800784","volume":"20","author":"H. Sakashita","year":"2007","unstructured":"Sakashita H, Haga H, Ashihara E, Wen MC, Tsuji H, Miyagawa-Hayashino A, et al. Significance of C4d staining in ABO-identical\/compatible liver transplantation. Mod Pathol 2007;20:676\u2013684.","journal-title":"Mod Pathol"},{"key":"1298_CR12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2559.2007.02677.x","volume":"50","author":"C.O. Bellamy","year":"2007","unstructured":"Bellamy CO, Herriot MM, Harrison DJ, Bathgate AJ. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology 2007;50:739\u2013749.","journal-title":"Histopathology"},{"key":"1298_CR13","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/01.TP.0000161667.99145.20","volume":"79","author":"Y. Tanaka","year":"2005","unstructured":"Tanaka Y, Ohdan H, Onoe T, Mitsuta H, Tashiro H, Itamoto T, et al. Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation 2005;79:1262\u20131267.","journal-title":"Transplantation"},{"key":"1298_CR14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0041-1345(02)03883-6","volume":"35","author":"Y. Tanaka","year":"2003","unstructured":"Tanaka Y, Ohdan H, Zhou W, Onoe T, Hara H, Tokita D, et al. Enzyme-linked immunospot assay for detecting cells secreting antibodies against human blood group A epitopes. Transplant Proc 2003;35:555\u2013556.","journal-title":"Transplant Proc"},{"key":"1298_CR15","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/00007890-200206270-00002","volume":"73","author":"M. Tanemura","year":"2002","unstructured":"Tanemura M, Ogawa H, Yin DP, Chen ZC, DiSesa VJ, Galili U. Elimination of anti-Gal B cells by alpha-Gal ricin1. Transplantation 2002;73:1859\u20131868.","journal-title":"Transplantation"},{"key":"1298_CR16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.iy.11.040193.002441","volume":"11","author":"A.B. Kantor","year":"1993","unstructured":"Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993;11:501\u2013538.","journal-title":"Annu Rev Immunol"},{"key":"1298_CR17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1084\/jem.172.4.1055","volume":"172","author":"R. Namikawa","year":"1990","unstructured":"Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM. Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 1990;172:1055\u20131063.","journal-title":"J Exp Med"},{"key":"1298_CR18","first-page":"68","volume":"67","author":"S. Neron","year":"1994","unstructured":"Neron S, Lemieux R. Type 2 T-cell-independent murine immune response to the human ABO blood group antigens. Vox Sang 1994;67:68\u201374.","journal-title":"Vox Sang"},{"key":"1298_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/08820139709088546","volume":"26","author":"S. Neron","year":"1997","unstructured":"Neron S, Lemieux R. CD5+ B cell-dependent regulation of the murine T-cell independent immune response against the human blood group A antigen. Immunol Invest 1997;26:631\u2013647.","journal-title":"Immunol Invest"},{"key":"1298_CR20","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.transproceed.2005.03.129","volume":"37","author":"W. Zhou","year":"2005","unstructured":"Zhou W, Ohdan H, Asahara T. Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation. Transplant Proc 2005;37:1808\u20131811.","journal-title":"Transplant Proc"},{"key":"1298_CR21","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.4049\/jimmunol.164.6.2924","volume":"164","author":"L.W. Arnold","year":"2000","unstructured":"Arnold LW, McCray SK, Tatu C, Clarke SH. Identification of a precursor to phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1. J Immunol 2000;164:2924\u20132930.","journal-title":"J Immunol"},{"key":"1298_CR22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJM198101153040308","volume":"304","author":"W.I. Bensinger","year":"1981","unstructured":"Bensinger WI, Baker DA, Buckner CD, Clift RA, Thomas ED. Immunoadsorption for removal of A and B blood-group antibodies. N Engl J Med 1981;304:160\u2013162.","journal-title":"N Engl J Med"},{"key":"1298_CR23","doi-asserted-by":"crossref","first-page":"13 459","DOI":"10.1073\/pnas.2233620100","volume":"100","author":"R. Berland","year":"2003","unstructured":"Berland R, Wortis HH. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc Natl Acad Sci USA 2003;100:13 459\u201313 464.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1298_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/intimm\/3.5.467","volume":"3","author":"Y.Z. Cong","year":"1991","unstructured":"Cong YZ, Rabin E, Wortis HH. Treatment of murine CD5-B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol 1991;3:467\u2013476.","journal-title":"Int Immunol"},{"key":"1298_CR25","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1084\/jem.188.12.2381","volume":"188","author":"M. Boes","year":"1998","unstructured":"Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998;188:2381\u20132386.","journal-title":"J Exp Med"},{"key":"1298_CR26","doi-asserted-by":"crossref","unstructured":"Irei T, Ohdan H, Zhou W, Ishiyama K, Tanaka Y, Ide K, Asahara T. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation. Blood. 2007 Aug 31; [Epub ahead of print]","DOI":"10.1182\/blood-2007-04-082719"},{"key":"1298_CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/smim.1996.0026","volume":"8","author":"M.G. Roncarolo","year":"1996","unstructured":"Roncarolo MG, Carballido JM, Rouleau M, Namikawa R, de Vries JE. Human T-and B-cell functions in SCID-hu mice. Semin Immunol 1996;8:207\u2013213.","journal-title":"Semin Immunol"},{"key":"1298_CR28","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.4049\/jimmunol.153.12.5503","volume":"153","author":"S.M. Wells","year":"1994","unstructured":"Wells SM, Kantor AB, Stall AM. CD43 (S7) expression identifies peripheral B cell subsets. J Immunol 1994;153:5503\u20135515.","journal-title":"J Immunol"},{"key":"1298_CR29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM200103153441102","volume":"344","author":"L.J. West","year":"2001","unstructured":"West LJ, Pollock-Barziv SM, Dipchand AI, Lee KJ, Cardella CJ, Benson LN, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001;344:793\u2013800.","journal-title":"N Engl J Med"},{"key":"1298_CR30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/intimm\/8.4.533","volume":"8","author":"A.C. Whitmore","year":"1996","unstructured":"Whitmore AC, Haughton G, Arnold LW. Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int Immunol 1996;8:533\u2013542.","journal-title":"Int Immunol"},{"key":"1298_CR31","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.4049\/jimmunol.166.4.2163","volume":"166","author":"H.H. Wortis","year":"2001","unstructured":"Wortis HH, Berland R. Cutting edge commentary: origins of B-1cells. J Immunol 2001;166:2163\u20132166.","journal-title":"J Immunol"},{"key":"1298_CR32","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.92.8.3348","volume":"92","author":"H.H. Wortis","year":"1995","unstructured":"Wortis HH, Teutsch M, Higer M, Zheng J, Parker DC. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci U S A 1995;92:3348\u20133352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1298_CR33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1432-2277.2003.tb00303.x","volume":"16","author":"A. Wu","year":"2003","unstructured":"Wu A, Buhler LH, Cooper DK. ABO-incompatible organ and bone marrow transplantation: current status. Transpl Int 2003;16:291\u2013299.","journal-title":"Transpl Int"},{"key":"1298_CR34","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.transproceed.2005.03.129","volume":"37","author":"W. Zhou","year":"2005","unstructured":"Zhou W, Ohdan H, Asahara T. Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation. Transplant Proc 2005;37:1808\u20131811.","journal-title":"Transplant Proc"},{"key":"1298_CR35","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1600-6143.2007.01901.x","volume":"7","author":"H. Ohdan","year":"2007","unstructured":"Ohdan H, Zhou W, Tanaka Y, Irei T, Fuchimoto Y, Egawa H, Asahara T. Evidence of immune tolerance to blood group antigens in a case of ABO-incompatible pediatric liver transplantation. Am J Transplant. 2007;7:2190\u20132194.","journal-title":"Am J Transplant"},{"key":"1298_CR36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00007890-200206270-00021","volume":"73","author":"M. Tanabe","year":"2002","unstructured":"Tanabe M, Shimazu M, Wakabayashi G, Hoshino K, Kawachi S, Kadomura T, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation. 2002;73:1959\u20131961.","journal-title":"Transplantation"},{"key":"1298_CR37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/lt.20705","volume":"12","author":"K. Tanaka","year":"2006","unstructured":"Tanaka K, Ozawa K, Teramukai S, Takada Y, Egawa H, Kaihara S, et al. Classification of human liver transplant recipients by their preoperative CD8 cell subpopulation and its relation to outcome. Liver Transpl 2006;12:792\u2013800.","journal-title":"Liver Transpl"},{"key":"1298_CR38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/lt.21065","volume":"13","author":"K. Tanaka","year":"2007","unstructured":"Tanaka K, Uemoto S, Egawa H, Takada Y, Ozawa K, Teramukai S, et al. Cytotoxic T-cell-medicated defense against infections in human liver transplant recipients. Liver Transpl 2007;13:287\u2013293.","journal-title":"Liver Transpl"}],"container-title":["Journal of Hepato-Biliary-Pancreatic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00534-007-1298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00534-007-1298-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00534-007-1298-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T13:30:39Z","timestamp":1684330239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00534-007-1298-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1007\/s00534-007-1298-2","relation":{},"ISSN":["0944-1166","1436-0691"],"issn-type":[{"value":"0944-1166","type":"print"},{"value":"1436-0691","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}